These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32875467)

  • 1. Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma.
    Suenaga M; Fujii T; Yamada S; Hayashi M; Shinjo K; Takami H; Niwa Y; Sonohara F; Shimizu D; Kanda M; Kobayashi D; Tanaka C; Nakayama G; Koike M; Fujiwara M; Kondo Y; Kodera Y
    Ann Surg Oncol; 2021 Apr; 28(4):2277-2286. PubMed ID: 32875467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.
    Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
    Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
    Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
    Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Resectability Status.
    Sakoda T; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Takahashi S
    J Gastrointest Surg; 2021 Nov; 25(11):2871-2880. PubMed ID: 33768425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
    Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
    J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer.
    Yukawa N; Yamada T; Aoyama T; Woo T; Ueda K; Mastuda A; Hara K; Kazama K; Tamagawa H; Sato T; Oshima T; Suzuki A; Aburatani H; Ishikawa S; Saito A; Masuda M; Yoshida H; Rino Y
    Anticancer Res; 2023 May; 43(5):2069-2076. PubMed ID: 37097663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of positive peritoneal lavage cytology early after fine needle aspiration in patients with pancreatic ducal adenocarcinoma.
    Sakamoto T; Onda S; Shirai Y; Tsunematsu M; Okui N; Gocho T; Ikegami T
    Pancreatology; 2023 Mar; 23(2):201-203. PubMed ID: 36702676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.
    Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K;
    Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative risk factors for positivity of peritoneal lavage cytology in patients with pancreatic ductal adenocarcinoma in the era of neoadjuvant therapy.
    Otsuka H; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Murakami Y; Takahashi S
    Pancreatology; 2022 Jun; 22(5):583-589. PubMed ID: 35466060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term adjuvant chemotherapy after resection for pancreatic cancer patients with positive peritoneal lavage cytology.
    Ohgi K; Sugiura T; Okamura Y; Ashida R; Yamada M; Otsuka S; Todaka A; Uesaka K
    Langenbecks Arch Surg; 2023 Apr; 408(1):165. PubMed ID: 37103587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic cancer.
    Aoki S; Mizuma M; Hayashi H; Yoshimachi S; Hata T; Miura T; Takadate T; Maeda S; Ariake K; Kawaguchi K; Masuda K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Motoi F; Unno M
    Pancreatology; 2020 Dec; 20(8):1711-1717. PubMed ID: 33032923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.
    Sato K; Mori R; Hiroshima Y; Oba MS; Matsuyama R; Bouvet M; Hoffman RM; Endo I
    J Surg Res; 2018 Jun; 226():122-130. PubMed ID: 29661277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma.
    Sergeant G; Roskams T; van Pelt J; Houtmeyers F; Aerts R; Topal B
    BMC Cancer; 2011 Jan; 11():47. PubMed ID: 21281486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of peritoneal cytology in potentially resectable pancreatic cancer.
    Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
    Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.
    Yamada S; Takeda S; Fujii T; Nomoto S; Kanazumi N; Sugimoto H; Kasuya H; Kodera Y; Nagasaka T; Morita S; Nakao A
    Ann Surg; 2007 Aug; 246(2):254-8. PubMed ID: 17667504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer.
    Yoshioka R; Saiura A; Koga R; Arita J; Takemura N; Ono Y; Yamamoto J; Yamaguchi T
    World J Surg; 2012 Sep; 36(9):2187-91. PubMed ID: 22555286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection.
    Satoi S; Murakami Y; Motoi F; Uemura K; Kawai M; Kurata M; Sho M; Matsumoto I; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Hashimoto Y; Hirono S; Yamaue H; Honda G; Nagai M; Nakajima Y; Shinzeki M; Fukumoto T; Kwon AH
    J Gastrointest Surg; 2015 Jan; 19(1):6-14; discussion 14. PubMed ID: 25316482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients.
    Kubo H; Hiroshima Y; Mori R; Saigusa Y; Murakami T; Yabushita Y; Sawada Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
    Ann Surg Oncol; 2019 Dec; 26(13):4506-4514. PubMed ID: 31489551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology.
    Valletti M; Eshmuminov D; Gnecco N; Gutschow CA; Schneider PM; Lehmann K
    World J Surg Oncol; 2021 Aug; 19(1):245. PubMed ID: 34404403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.